ロード中...
Dexmedetomidine for the management of awake fibreoptic intubation
BACKGROUND: Awake fibreoptic intubation (AFOI) frequently requires sedation, anxiolysis and relief of discomfort without impairing ventilation and depressing cardiovascular function. The goal is to allow the patient to be responsive and co‐operative. Medications such as fentanyl, remifentanil, midaz...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2014
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095023/ https://ncbi.nlm.nih.gov/pubmed/24442817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009798.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|